Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for improving osteoarticular diseases, disintegrating tablet and preparation method thereof

A technology for bone and joint diseases and a composition, which is applied in the field of pharmaceutical compositions for improving bone and joint diseases, can solve the problems such as the inability of drugs for bone and joint diseases to meet diversified needs, and achieves the improvement of mechanical strength of bone tissue, improvement of symptoms, and relief of bone and joint diseases. Effects of joint pain

Inactive Publication Date: 2016-08-10
北京素维生物科技有限公司
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The main purpose of the present invention is to provide a pharmaceutical composition for improving bone and joint diseases, a disintegrating tablet and its preparation method, so as to solve the problem that the drugs for treating bone and joint diseases in the prior art cannot satisfy the diversification of related drugs or health products in the market. question of needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for improving osteoarticular diseases, disintegrating tablet and preparation method thereof
  • Pharmaceutical composition for improving osteoarticular diseases, disintegrating tablet and preparation method thereof
  • Pharmaceutical composition for improving osteoarticular diseases, disintegrating tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] It should be noted that, in the case of no conflict, the embodiments in the present application and the features in the embodiments can be combined with each other. The present invention will be described in detail below in conjunction with examples.

[0017] In this application, the main ingredient refers to the active ingredient, and the excipient refers to the auxiliary ingredient of the drug effect, including the drug ingredient that assists in enhancing the drug effect or the ingredients required for preparation of the drug. In terms of parts by weight, both the main material and the auxiliary material refer to the same weight as 1 part by weight for calculation.

[0018] As mentioned in the background technology section, the medicines or health products for improving the treatment of bone and joint diseases in the prior art cannot meet the diversified needs of the market. In order to increase the diversified needs of patients for such medicines or health products,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for improving osteoarticular diseases, a disintegrating tablet and a preparation method thereof. The pharmaceutical composition comprises main materials and auxiliary materials. The main materials are composed of, by weight, 90-120 parts of glucosamine and 0.001-0.05 part of vitamin K. The glucosamine can stimulate chondrocytes to synthesize protein polysaccharide and collagen fiber so as to generate cartilage matrix and repair articular cartilage. Vitamin K controls bone and calcium metabolism such that effective mineral deposition and retention of calcium intake on bones are guaranteed, bone quality and bone mineral density are enhanced and repairing function of articular cartilage is effectively raised. By using glucosamine and vitamin K as the main material and controlling ratio of the two components within the above range, the two active components have a synergistic interaction so as to raise mechanical strength of bone tissues of a patent, effectively inhibit decline in bone mineral density of middle-aged and old people, completely improve symptoms of osteoarthritis and mitigate arthralgia. Therefore, bone health problems such as bone aging of middle-aged and old people are alleviated.

Description

technical field [0001] The invention relates to the field of medicine and health care, in particular to a pharmaceutical composition for improving bone and joint diseases, a disintegrating tablet and a preparation method thereof. Background technique [0002] Osteoarthritis is the most common joint disease, which is defined by the American College of Rheumatology as a heterogeneity of joint symptoms and signs caused by damage to the integrity of articular cartilage, subchondral bone plate and joint edge bone lesions Disease, that is, a chronic joint disease of degeneration of articular cartilage and secondary bone hyperplasia. Its main symptoms are pain and loss of function caused by the degeneration of articular cartilage. When a person enters middle age, the joint tissue begins to age slowly, and degenerative lesions appear, especially the weight-bearing knee and spinal joints are most vulnerable to damage. Among people aged 50 to 60, more than half suffer from osteoarth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7008A61K9/20A61P19/02A61P19/08A61P19/10A61K31/122A61K31/05
CPCA61K9/0056A61K31/05A61K31/122A61K31/7008A61K9/2054A61K2300/00
Inventor 陈曼寇爽佘佐彦
Owner 北京素维生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products